Approval · Notice of Compliance 23142 · 2020
ENTECAVIR TABLETS: Notice of Compliance 23142
Issued January 23, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23142
- Date
- January 23, 2020
- Company
- Strides Pharma Canada IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Change in product ownership
- Canadian reference product
- BARACLUDE (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTECAVIR TABLETS | 02453797 | Marketed |
Medicinal ingredients
- ENTECAVIR 0.5 MG per TAB